NR507 / NR 507 Mid-Term Exam Study Guide Updated: Advanced Pathophysiology - Chamberlain

Document Content and Description Below

NR-507 Advanced Pathophysiology Mid-Term Exam Study Guide NR-507 Advanced Pathophysiology Mid-Term Exam Study Guide Pulmonary: review concepts related to anticholinergic drugs and the... treatment for asthma, bronchitis and associated pathogenesis; chronic bronchitis and related acid/base disturbances, perfusion, blood flow between the heart and lungs, asthma signs and symptoms, bronchioles, alveolar hyperinflation with asthma, polycythemia vera; mechanism of action of anticholinergic drugs to treat asthma Anticholinergic drugs/Mechanism of action of anticholinergic drugs to treat asthma - block acetylcholine binding (primarily in lung) promoting bronchodilation through a decrease in parasympathetic response o tiotropium, ipratropium Treatment for asthma - Pharmacotherapy focuses on the bronchoconstriction and/or inflammation to provide fast relief for bronchospasms and long-term control to reduce the frequency of asthma attacks - Fast-acting medications o Short acting beta2-adrenergic agonists (SABA) – activate beta receptors (primarily in lung) through the release of epinephrine promoting bronchodilation through an enhanced sympathetic response  Albuterol o Anticholinergic agents – block acetylcholine binding (primarily in lung) promoting bronchodilation through a decrease in parasympathetic response  Tiotropium  Ipratropium o Oral corticosteroids – inhibit inflammatory cell and chemical production causing a reduction in the inflammatory process  Prednisone  Prednisolone  Methylprednisone [Show More]

Last updated: 2 years ago

Preview 1 out of 14 pages